In a latest note to investors, a research analyst has provided a rating update for the WELL Health Technologies Corp (WELL – Research Report). CIBC’s analyst Scott Fletcher reiterates their Buy rating on the shares, with a C$6.50 price target.
According to TipRanks.com, Fletcher is ranked #7376 out of 8547 analysts.
WELL Health Technologies Corp has an analyst consensus of Strong Buy, with a price target consensus of C$8.96, implying a 95.6% upside from current levels. In a report issued on July 27, Stifel Nicolaus also maintained a Buy rating on the stock.
WELL Health Technologies Corp’s market cap is currently C$1.08B and has a P/E ratio of -244.68.
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.
The company’s shares closed last Friday at C$4.30.
Read More on TSE:WELL:
- WELL Health Reports Record Results for Q2-2023 and Upgrades Guidance for Balance of Year
- WELL Earnings this Week: How Will it Perform?
- WELL Health to Enter into Strategic Alliance with MCI Onehealth, Acquire Clinical Assets, and Invest in AI-Focused Data Science Business to help Doctors Improve Disease Detection
- WELL Health Announces the Acquisition of CarePlus Management and Increases Annual Revenue Guidance
